Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services, Inc.    WST

WEST PHARMACEUTICAL SERVICES, INC.

(WST)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/18/2020 11/19/2020 11/20/2020 11/23/2020 11/24/2020 Date
281.29(c) 281.22(c) 284.73(c) 275.72(c) 267.71(c) Last
358 031 391 427 351 282 300 025 461 794 Volume
-1.92% -0.02% +1.25% -3.16% -2.91% Change
More quotes
Financials (USD)
Sales 2020 2 114 M - -
Net income 2020 340 M - -
Net Debt 2020 - - -
P/E ratio 2020 59,3x
Yield 2020 0,24%
Sales 2021 2 348 M - -
Net income 2021 378 M - -
Net Debt 2021 - - -
P/E ratio 2021 53,7x
Yield 2021 0,26%
Capitalization 19 791 M 19 791 M -
Capi. / Sales 2020 9,36x
Capi. / Sales 2021 8,43x
Nbr of Employees 8 200
Free-Float 97,6%
More Financials
Company
West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical... 
More about the company
Notations Surperformance© of West Pharmaceutical Services, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about WEST PHARMACEUTICAL SERVICES, INC.
11/09WEST PHARMACEUTICAL SERVICES INC : Change in Directors or Principal Officers, Fi..
AQ
11/09WEST PHARMACEUTICAL SERVICES : Appoints Kimberly Banks MacKay as Senior Vice Pre..
PR
11/09WEST PHARMACEUTICAL SERVICES, INC. : Ex-dividend day for
FA
10/29WEST PHARMACEUTICAL SERVICES : Announces Increase to Fourth-Quarter 2020 Dividen..
AQ
10/28WEST PHARMACEUTICAL SERVICES INC : Regulation FD Disclosure, Financial Statement..
AQ
10/28WEST PHARMACEUTICAL SERVICES : Announces Increase to Fourth-Quarter 2020 Dividen..
PR
10/23WEST PHARMACEUTICAL SERVICES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
AQ
10/23WEST PHARMACEUTICAL SERVICES : Announces Third-Quarter 2020 Results
AQ
10/23WEST PHARMACEUTICAL SERVICES : Launches New Vial2Bag Advanced 20mm Admixture Dev..
AQ
10/22WEST PHARMACEUTICAL SERVICES : Launches New Vial2Bag Advanced™ 20mm Admixt..
PR
10/22WEST PHARMACEUTICAL SERVICES : Q3 2020 Earnings Conference Call Presentation
PU
10/22WEST PHARMACEUTICAL SERVICES INC : Results of Operations and Financial Condition..
AQ
10/22WEST PHARMACEUTICAL : 3Q Earnings Snapshot
AQ
10/22WEST PHARMACEUTICAL SERVICES : Announces Third-Quarter 2020 Results
PR
10/19WEST PHARMACEUTICAL SERVICES, INC. : quaterly earnings release
More news
News in other languages on WEST PHARMACEUTICAL SERVICES, INC.
10/19WEST PHARMACEUTICAL SERVICES, INC. : publication des résultats trimestriels
10/19WEST PHARMACEUTICAL SERVICES, INC. : Veröffentlichung des Quartalsergebnisses
10/02Kühne+Nagel signe un nouveau contrat de logistique en Irlande
07/20WEST PHARMACEUTICAL SERVICES, INC. : Veröffentlichung des Halbjahresergebnisses
07/20WEST PHARMACEUTICAL SERVICES, INC. : publication des résultats semestriels
More news
Chart WEST PHARMACEUTICAL SERVICES, INC.
Duration : Period :
West Pharmaceutical Services, Inc. Technical Analysis Chart | WST | US9553061055 | MarketScreener
Technical analysis trends WEST PHARMACEUTICAL SERVICES, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 276,83 $
Last Close Price 267,71 $
Spread / Highest target 30,7%
Spread / Average Target 3,41%
Spread / Lowest Target -36,1%
EPS Revisions
Managers
NameTitle
Eric Mark Green President, Chief Executive Officer & Director
David A. Montecalvo SVP-Global Operations & Supply Chain
Bernard J. Birkett Chief Financial Officer, Treasurer & Senior VP
Eric Resnick Chief Technology Officer & Vice President
Paula A. Johnson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
WEST PHARMACEUTICAL SERVICES, INC.83.41%19 791
ABBOTT LABORATORIES23.89%190 724
MEDTRONIC PLC0.54%152 963
BECTON, DICKINSON AND COMPANY-15.69%66 464
HOYA CORPORATION29.62%46 912
BAXTER INTERNATIONAL INC.-9.08%38 838